Citing unique health risks of tobacco, investors support carve-out in Trans-Pacific Partnership (TPP) commercial agreements; express concerns for the potential of TPP to limit access to medicines.
In light of recent wave of scandals, management commits to comprehensive reporting of steps taken to mitigate risk.
Choice to Place Public Health above Corporate Profits Heralded as Watershed Moment for Retail Pharmacy Sector by Long-Term Shareholders NEW YORK, NEW YORK, Wednesday, February 5, 2014 – In a move investors hope represents a “tipping point” for the retail pharmacy sector, CVS Caremark announced today that it would end tobacco sales in its chain […]
The largest chocolate producer in North America on track to source 100% certified cocoa by 2020 NEW YORK, NY, Friday, January 31st, 2014– Today members of the Interfaith Center on Corporate Responsibility and investors in the Hershey Company were heartened by its announcement that, as of year-end 2013, 18% of its cocoa was […]
We applaud the decision taken by the DC District Court decision on July 23rd to uphold the implementing rules for Section 1502 of the Dodd-Frank Act and to dismiss the lawsuit filed against the Securities and Exchange Commission (SEC) by the U.S. Chamber of Commerce, the National Association of Manufacturers, and the Business Roundtable. As […]
Persistence of shareholders calling for end to predatory lending program pays off. NEW YORK, NY – Friday, January 17th: After a long-term engagement with Wells Fargo to promote more responsible lending products, today members of the Interfaith Center on Corporate Responsibility (ICCR) wish to commend management for making the right decision in ending its Direct […]
Members of the Interfaith Center on Corporate Responsibility announce month-long initiative during January, Human Trafficking Awareness month, to counter trafficking and slavery in high-risk sectors. NEW YORK, NY///December 10, 2013/In commemoration of Human Rights Day 2013, today members of the Interfaith Center on Corporate Responsibility, a coalition of faith-based and socially responsible investors, announced that […]
Licensing agreement reached for generic production of adult and pediatric Atazanavir shows leadership and innovation in delivering HIV/AIDS medicines where they are most needed. New York, NY, Thursday, December 12th, 2013 – Members of the Interfaith Center on Corporate Responsibility (ICCR) today applaud Bristol-Myers Squibb (BMS) for successfully negotiating an agreement with the Medicines Patent […]
The ICCR community mourns the loss of Nelson Mandela, champion for equality and human rights, peacemaker and icon of hope for reconciliation and justice. Our thoughts and prayers go out to his family and countrymen. Forty-three years ago, witnessing the selfless struggle of Mandela and others who rejected the inequality and racism symbolized by the […]
Patent Sharing for Key Medications Urged to Strengthen Results for an AIDS-Free Generation NEW YORK, NY – WEDNESDAY, NOVEMBER 27, 2013–In anticipation of World Aids Day, Sunday, December 1st, 2013, members of the Interfaith Center on Corporate Responsibility (ICCR) renew their call for companies that make medicines that treat HIV/AIDS to join the Medicines Patent […]
Members of the press seeking comment/interviews with ICCR staff or members should contact ICCR’s Director of Communications, Susana McDermott: Email: smcdermott@iccr.org
